Clinical Trial Update: Study of a Pembrolizumab-based Organ Preservation Strategy for Locally Advanced Larynx Cancers [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial, sponsored by the Latin American Cooperative Oncology Group, is evaluating a pembrolizumab-based organ preservation strategy for loc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngeal Squamous Cell Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Latin American Cooperative Oncology Group | Conditions: Squamous Cell Carcinoma of Larynx | Phase 2 | Status: ACTIVE_NOT_RECRUITING